HIV-1 GP41 neutralization domain and use thereof
US8475799B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 11, 2008 |
| Grant date | Jul 2, 2013 |
| Priority date | — |
| Expiry date | Oct 20, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to isolated monoclonal antibodies which specifically bind to the C-terminal heptad repeat region of gp41 (HR2) and neutralize an HIV-1 primary isolate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.